Name | [(2R,5S)-5-(4-amino-2-oxopyrimidin-1-yl)-1,3-oxathiolan-2-yl]methyl 2-hydroxybenzoate |
---|---|
Synonyms |
2-Hydroxybenzoic acid - 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone (1:1)
Benzoic acid, 2-hydroxy-, compd. with 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone (1:1) lamivudine salicylate |
Description | Lamivudine (BCH-189) salicylate is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine salicylate can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C15H17N3O6S |
---|---|
Molecular Weight | 367.377 |
Exact Mass | 367.083801 |
PSA | 173.20000 |
LogP | 1.07750 |
~% 173522-96-8 |
Literature: WO2009/69012 A1, ; Page/Page column 22-23 ; |
~% 173522-96-8 |
Literature: WO2009/69011 A1, ; Page/Page column 17-18 ; |
Precursor 3 | |
---|---|
DownStream 1 | |